| Bioactivity | DPM-1003 is a PTP1B conformational inhibitor that targets the non-catalytic, disordered segment at the C-terminus of the PTP1B protein, showing improvement in lung inflammation in mice[1]. |
| CAS | 3018836-86-4 |
| Formula | C35H57N3O3 |
| Molar Mass | 567.85 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Dongyan Song, et al. PTP1B inhibitors protect against acute lung injury and regulate CXCR4 signaling in neutrophils. JCI Insight. 2022 Jul 22;7(14):e158199. |
DPM-1003
CAS: 3018836-86-4 F: C35H57N3O3 W: 567.85
DPM-1003 is a PTP1B conformational inhibitor that targets the non-catalytic, disordered segment at the C-terminus of the
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.